Key regulatory developments in the Russian life-sciences sector – December 2017

| By | Life Sciences, Regulatory, Trubor Online

Maria Borzova, council of Trubor law firm, goes over the most important life-science regulatory updates.

In this video, you will get an idea about the current regulatory landscape of the Russian pharmaceutical sector as of December 2017, Risk-map for 2018, and general recommendations for the strategy planning.

SOURCE: Trubor Online
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.